Compare SPXC & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPXC | RGC |
|---|---|---|
| Founded | 1912 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 11.5B |
| IPO Year | 1994 | 2020 |
| Metric | SPXC | RGC |
|---|---|---|
| Price | $214.07 | $5.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $245.56 | N/A |
| AVG Volume (30 Days) | ★ 604.3K | 568.6K |
| Earning Date | 04-30-2026 | 10-31-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.08 | N/A |
| EPS | ★ 1.19 | N/A |
| Revenue | ★ $2,265,100,000.00 | N/A |
| Revenue This Year | $16.07 | N/A |
| Revenue Next Year | $7.68 | N/A |
| P/E Ratio | $181.06 | ★ N/A |
| Revenue Growth | ★ 14.17 | N/A |
| 52 Week Low | $171.31 | $4.67 |
| 52 Week High | $251.08 | $69.00 |
| Indicator | SPXC | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 41.93 | 26.59 |
| Support Level | $201.06 | N/A |
| Resistance Level | $227.78 | $29.26 |
| Average True Range (ATR) | 8.27 | 1.15 |
| MACD | -2.21 | 0.44 |
| Stochastic Oscillator | 17.19 | 12.18 |
SPX Technologies Inc supplies engineered heating, ventilation, and air conditioning, or HVAC, products, as well as detection and measurement technologies and power equipment. The company operates through two reportable segments. The HVAC segment which generates the majority of the revenue for the company, designs, manufactures, installs, and services cooling products, as well as heating and ventilation products. The Detection and Measurement technologies segment designs, manufactures, and installs underground pipe and cable locators and inspection equipment, bus-fare collection systems, and others. Geographically, the company has its operations in the United States, Canada, China, the United Kingdom, and Others. It derives maximum revenue from United States.
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.